A lot of people turn to weight loss drugs hoping for a quick, effective way to improve their health. Shedding pounds fast sounds great until the side effects kick in. Drugs like Ozempic, Wegovy, Mounjaro, and Saxenda have been linked to serious problems, like stomach paralysis, gallbladder issues, and long-term digestive trouble. What started as hope for better health turned into hospital stays, missed work, painful procedures, and a lot of unanswered questions. Week after week, more patients come forward with nearly identical horror stories.
If this describes your experience, trust this: your concerns are valid and shared by thousands. A mounting legal response is exposing the true dangers of these medications and the questionable marketing practices behind them. Victims nationwide are uniting to demand justice by joining the ongoing weight loss drug lawsuit efforts.
This article breaks down the latest on weight loss drug lawsuits, from the current Mounjaro lawsuit update today to the broader receptor agonist class action. We’ll cover major claims like the leading Rybelsus claim, updates on the Ozempic class action lawsuit, and what’s happening with Saxenda, Wegovy, and similar drugs. If you’re trying to understand your legal options, this guide will give you the essential information you need to understand your rights and next steps.
As of April 2026, lawsuits tied to popular weight loss drugs have grown to more than 3,500 cases in the U.S. Most of them are now being handled together in two multi district litigations in Pennsylvania, overseen by Judge Karen S. Marston.
MDL 3094 (Stomach and digestive injuries): This is the largest group, with about 3,363 cases. These lawsuits involve serious stomach problems like gastroparesis (slow or paralyzed stomach), ileus, and bowel blockages.
MDL 3163 (Vision loss): This smaller group has about 73 cases. These claims involve sudden, permanent vision loss linked to a condition called NAION.
No nationwide settlement has been reached yet with Novo Nordisk or Eli Lilly.
Litigation Developments
Let’s face it, changing what you eat and how you live is hard. That’s exactly why so many people look to weight loss medications for help. These prescriptions work by dialing down your hunger and making cravings more manageable. When you’re not fighting constant hunger pangs, eating less just happens naturally. And that’s how the pounds start coming off: by consistently taking in fewer calories than you burn.
The numbers tell the story: Americans spend about $2.1 billion annually on weight loss supplements, according to the National Institutes of Health. And roughly 15% of U.S. adults have tried them, usage is nearly twice as high among women (21%) compared to men (10%). The FDA has approved several of these medications, but their popularity doesn’t mean they’re right for everyone.
Today, weight loss drugs, especially newer GLP-1 receptor agonists, have become valuable tools for managing obesity. While they offer more effective and safer options than older medications, they’re not magic pills. Doctors stress that these drugs should only be used under careful medical supervision, balancing potential benefits against risks.
One thing remains clear: No medication replaces healthy habits. The 2025 Dietary Guidelines for Americans reaffirm that lasting weight loss still hinges on lifestyle changes, like nutritious eating, calorie awareness, and regular activity. Supplements and medications are just one piece of a much bigger picture.
Weight loss meds help in a few main ways:
Each one works a little differently, but the idea is the same: help you eat less and burn more. That said, they’re not meant to replace good habits. They work best when you’re also eating better and staying active. These meds are a boost, not a fix-all.
These meds aren’t for everyone. They’re usually for adults who’ve tried to lose weight through eating better and moving more but haven’t gotten the results they need.
Most of the time, doctors prescribe them if:
Some of those health issues might include:
In some cases, people with rare genetic causes of obesity might also qualify. These drugs can make a real difference but they’re part of a bigger plan, not a quick fix.
Here’s a rundown of the weight loss meds that have full FDA approval for long-term use. These aren’t just appetite suppressants. They each work in different ways to help with weight management, and they’re all approved for specific age groups and health conditions:
These meds aren’t one-size-fits-all, and they’re not meant to replace healthy habits. But they can be a powerful part of a bigger plan for people who qualify.
Some medications originally designed for type 2 diabetes are now commonly used for weight loss, either off-label or at higher doses that are FDA-approved for managing weight. Many of these work by slowing down digestion, reducing hunger, or helping your body lose extra calories through urine.
Here’s a breakdown of the main ones:
Weight loss usually ranges from about 3 to 5 pounds over 6 months.
A Few Quick Notes
Just like with weight loss–specific meds, lifestyle changes still matter. These drugs work best when combined with better eating habits and regular activity. And if you stop taking them, weight often creeps back.
Most people using weight loss drugs while making lifestyle changes lose between 5-10% of their body weight. In medical terms, it’s enough to make a real difference in health outcomes.
Some of the newer options are changing expectations though. Take Zepbound (tirzepatide). In clinical trials, many patients saw 15% or greater weight reduction after a full year. But here’s the thing no one tells you upfront: your results will depend on which medication you’re prescribed, the dosage that works for you, and how your body responds.
These drugs work best when you’re also putting in the work with better food choices and regular movement. And there’s another hard reality: if you stop taking them, the weight often comes back. That’s because obesity isn’t a temporary condition; it’s something most people need to manage long-term.
The good news? Even that 5-10% weight loss doctors talk about can lead to noticeable improvements: Better blood pressure numbers, improved blood sugar control, and healthier cholesterol levels. At the end of the day, these medications are tools, helpful for many, but not instant solutions. The most successful patients use them as part of a complete approach to health.
Here’s a quick look at the weight loss meds people are actually using in 2025. Some are household names by now, thanks to their popularity on social media and growing demand across the country.
These medications don’t all work the same way, but they’re some of the most widely prescribed and talked-about options for weight management right now. Some are designed specifically for weight loss, while others started as diabetes treatments and later got the green light for weight-related use.
What does semaglutide vs GLP-1 drugs mean? Semaglutide is one medication in a wider group called GLP-1 receptor agonists. These drugs all work by acting like a natural hormone that helps control blood sugar, slow digestion, and reduce appetite, which is why they’re used for diabetes and weight loss. Semaglutide, found in Ozempic and Wegovy, lasts longer in the body, so it’s usually taken once a week. Other GLP-1 drugs like liraglutide are taken daily. Some studies show semaglutide may offer slightly stronger results in blood sugar control and weight loss.
Like anything else in healthcare, weight loss drugs come with both upsides and downsides. Knowing both can help you make a more informed decision.
Pros:
Cons:
Medications like Ozempic, Wegovy, Mounjaro, Rybelsus, and Saxenda are everywhere right now when it comes to weight loss. But here’s the thing, only Wegovy and Saxenda are actually FDA-approved for weight management. The rest are technically diabetes meds, though doctors often prescribe them for weight loss too. Regardless of how they’re used, these GLP-1 drugs share many of the same potential side effects, and it’s important to understand what you might be signing up for. Let’s break it down, from the more common side effects to the rare but serious risks.
These meds tend to affect the digestive system the most, but they can also impact other parts of the body. Here are some general categories of side effects seen across the board:
For popular weight loss drugs:
Mild effects:
These symptoms usually show up as your dose increases but tend to fade with time.
Serious risks:
Common complaints:
More serious side effects:
Typical side effects:
Serious side effects:
Milder side effects:
More severe reactions:
Most common side effects:
These usually show up early and often improve with time.
More serious risks:
It’s important to weigh the benefits against the risks and talk with a healthcare provider about what makes sense for your body and your health goals. Informed choices matter.
Drugs like Ozempic, Wegovy, Saxenda, Mounjaro, Rybelsus, and Trulicity have seen a sharp rise in use over the past few years. Originally designed to help manage type 2 diabetes, these medications are now widely used for weight loss as well. But while many people have found success with these drugs, others have experienced serious side effects, and lawsuits are following.
A growing number of people are taking legal action, claiming these medications caused significant harm and that the drugmakers didn’t do enough to warn users about the risks. These lawsuits have been grouped into a multidistrict litigation (MDL). The MDL titled In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation (MDL No. 3094) is centralized in the Eastern District of Pennsylvania. This allows the courts to handle similar claims together instead of separately, making the process more efficient.
The lawsuits center on GLP-1 receptor agonist medications made by:
Most of the claims argue that the manufacturers failed to give patients and doctors proper warnings about the potential risks. Some of the most serious complications reported include:
Many people say they would have chosen a different treatment, or at least been more closely monitored, if they had known about these risks upfront.
Some of the key legal questions in the MDL include:
You may be eligible to file a claim, depending on your state’s statute of limitations, if you:
As of mid-2025, more than 1,800 lawsuits are active in the MDL. The legal process is moving forward, with discovery and expert reviews underway. The drug manufacturers are defending their products, and no major settlements have been reached yet. However, Ozempic attorneys are still reviewing new cases and encouraging those who’ve been affected to explore their legal options.
As of April 2026, the GLP-1 weight loss drug litigation (MDL No. 3094) has grown quickly, with over 3,400 cases involving gastrointestinal injuries, along with a related MDL (No. 3163) for vision loss (NAION), up from 1,800 cases in May 2025. The court is managing the process through a series of structured deadlines and hearings designed to keep things moving efficiently while both sides build their cases.
Here’s a look at some of the major developments, both recent and upcoming, in the MDL:
In the background of these formal steps, plaintiffs are pushing back against attempts by the defense to limit the scope of the lawsuits. While the drug companies argue that failure-to-warn claims are the only valid ones, plaintiffs are also alleging fraud and defective design.
The court has held regular status conferences to keep things on track and is overseeing ongoing procedures like Plaintiff Fact Sheets and electronic filings. A “Science Day” has either been held or is on the calendar, where both sides present information about how these drugs might be causing injuries like gastroparesis.
Wegovy, Novo Nordisk’s weight loss drug, is facing a wave of lawsuits claiming the company didn’t properly warn users about serious side effects. These cases are now part of MDL No. 3094 in federal court in Philadelphia.
Users of Wegovy have reported severe health problems, especially:
Beyond digestive issues, lawsuits also link Wegovy to vision loss, blood clots, certain cancers, and neurological problems like ALS.
The core legal claims in Wegovy lawsuits are:
Though no official settlements are set yet, estimates suggest compensation could range from $400,000 to $700,000 for serious injuries. Each case depends on the facts and severity of harm.
Ozempic lawsuits are part of MDL No. 3094. They accuse Novo Nordisk and Eli Lilly of not warning users about serious side effects from semaglutide, the main ingredient in Ozempic.
People taking Ozempic have reported serious health problems like:
The core legal allegations in Ozempic lawsuits are:
The main question in a lawsuit against Ozempic is whether Novo Nordisk failed to properly warn users and misled them through its marketing. Plaintiffs want compensation for medical bills, pain, and other damages.
A key May 14, 2025, Rule 702 hearing reviewed whether expert testimony linking Ozempic to injuries like gastroparesis could be used in court. In August 2025, Judge Marston ruled that claims must be supported by objective medical testing, such as gastric emptying studies or other diagnostic tests, and dismissed design defect claims while allowing failure-to-warn and some marketing claims to continue. Defendants continue to push for dismissal in cases without strong medical evidence. Fact discovery closed in July 2025, expert discovery finished in March 2026, and summary judgment motions are ongoing as of April 2026. The court has also limited broader marketing discovery to focus on labeling issues, while short-form complaints continue to streamline new filings in MDL 3094, which now includes over 3,500 cases. No global settlement has been reached, and significant payouts are not expected before late 2026.
Saxenda lawsuits say Novo Nordisk didn’t properly warn patients and doctors about serious side effects from the drug. Saxenda is used for weight loss in adults and teens with obesity or a high BMI.
The legal claims in the GLP 1 lawsuits are:
Over 1,100 Saxenda lawsuits are now part of MDL No. 3094, alongside Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1 cases, bringing the total to more than 3,500 claims. As of April 2026, the litigation has moved past fact discovery (July 2025) and expert discovery (March 2026), and the court has already held the May 14, 2025, Rule 702 hearing requiring objective diagnostic testing to support injury claims. The case is now in summary judgment motions and bellwether selection, with trials expected in mid-2026.
No global settlement or trial verdicts have been reached yet. Some severe, well-documented cases have projected values of $400,000 to $700,000, but outcomes will depend on future rulings and trial results.
People are suing Eli Lilly over Mounjaro, a drug for diabetes and weight loss, saying it caused serious and sometimes lasting health problems. The main issue is that Eli Lilly didn’t properly warn patients and doctors about these risks.
Here’s what the Eli Lilly lawsuits say:
What’s happening now:
The cases are still in early stages, with important hearings coming in 2025 to decide how strong the science is linking Mounjaro to these injuries and if the warnings were good enough. Courts are looking closely at how gastroparesis is diagnosed and if the FDA-approved labels were enough. The first Mounjaro lawsuit about stomach paralysis was filed in August 2023.
Common side effects mentioned include:
As of April 2026, hundreds of Mounjaro (tirzepatide) cases remain active within MDL No. 3094, which now totals about 3,546 lawsuits across GLP-1 drugs. The litigation is now in the pretrial phase, with summary judgment motions and bellwether case selection underway after the close of fact discovery in July 2025 and expert discovery in March 2026. No settlements have been reached, and the outcome will largely depend on how early bellwether trials play out.
Rybelsus, a type 2 diabetes drug often used off-label for weight loss, is now at the center of growing lawsuits. People are saying the drug caused serious health problems, and that Novo Nordisk didn’t do enough to warn about them.
The Novo Nordisk lawsuits are saying:
In addition to gastrointestinal issues, there are separate lawsuits just for eye-related injuries like blindness linked to Rybelsus.
No settlements have been reached yet. Some sources suggest future payouts could range from $100,000 to $1 million, depending on the injuries, but that’s still speculative at this point.
If you’ve been hurt by a weight loss drug, it’s important to know what steps to take if you’re thinking about legal action. Here’s a quick breakdown of the process:
If you or a loved one suffered serious health issues after taking a weight loss drug like Ozempic, Wegovy, Rybelsus, Trulicity, or Mounjaro, you may qualify for a lawsuit. At Ethen Ostroff Law, we’re reviewing cases where people experienced severe side effects tied to these drugs.
Here’s what we look for in cases we accept:
You must have taken one of these medications:
You must have:
We’re currently taking cases involving any of these serious complications, either while taking the medication or within a few months of stopping:
If your experience matches any of these, reach out. These cases are time-sensitive, and it’s important to take action as soon as possible.
Victims of weight loss drug injuries have the option to join a GLP-1RA class action lawsuit rather than pursue an individual Wegovy and Ozempic lawsuit. Class action lawsuits involve a group of individuals who have suffered similar injuries due to the same product, such as a weight loss drug. Consider whether joining a class action is the right choice for you with the help of your attorney.
Benefits of joining a class action lawsuit include:
There’s a deadline for taking legal action after you’ve been harmed by a weight loss drug. It’s called the statute of limitations, and it varies depending on where you live. In Pennsylvania, the statute of limitations for product liability and personal injury claims is two years from the date of injury or the date the injury was discovered or reasonably should have been discovered.
You could lose the chance to file a claim and recover compensation if you miss that deadline. It’s important to talk to a lawyer as soon as you suspect something is wrong. They’ll help you figure out how much time you have and make sure everything gets filed on time.
For individuals harmed by medications like Ozempic or Mounjaro, successful legal claims may recover several types of damages:
The specific compensation available depends entirely on your individual circumstances. An experienced semaglutide attorney or liraglutide attorney can help pursue the fullest possible recovery.
Taking on a pharmaceutical company isn’t easy, especially when you’re dealing with serious health issues at the same time. These cases often involve complex medical records, expert testimony, and corporate legal teams that don’t make things simple.
That’s exactly why EOL.Law is here. Here’s how we will support you throughout your case:
Reach out to us today for a free consultation and find out if you qualify.
Yes, you could sue if you got hurt by Ozempic, Wegovy, Mounjaro, or Zepbound. You need proof you took the drug and medical records of stomach paralysis, bowel blockage, or vision loss. Most cases are grouped together in one big lawsuit. You can get compensation for medical bills and missed work.
You qualify if you took name-brand Ozempic for at least 30 days and got gastroparesis, ileus, or vision loss. You need medical records that prove your injury started while on the drug or right after stopping. You do not qualify if you are over 75, had stomach surgery before, or took compounded versions. Talk to a lawyer to check your case.
People are suing because Novo Nordisk did not warn that Ozempic could cause stomach paralysis and bowel blockages. The drug slows digestion, but the label only mentioned nausea, not permanent damage. Studies also show a link to sudden vision loss. Thousands of cases are now in court.
Same reason as above. Patients say the company hid the real risks of severe stomach injuries. The FDA also said Novo Nordisk did a bad job reporting bad reactions, including deaths. Lawsuits ask for compensation to cover hospital bills and suffering.
You need your prescription records showing you took name-brand Ozempic for at least 30 days. You also need test results like stomach-emptying scans, CTs, or eye exams that prove your injury. Hospital records and medical bills show what it costs you. A lawyer can help gather everything.
You need a lawyer because these cases are complicated, and drug companies have big legal teams. A lawyer gets your medical records, meets filing deadlines, and proves the drug caused your injury. Most lawyers work for free upfront and only get paid if you win. You will likely get more compensation with a lawyer than without one.
Saxenda is another weight loss drug made by the same company as Ozempic. Lawsuits say it caused stomach paralysis, bowel blockages, and gallbladder problems without proper warnings. These cases were added to the same group lawsuit as Ozempic in late 2024. People want compensation for medical bills and long-term health issues.
People complain about bad nausea, vomiting, constipation, and stomach pain from Zepbound. Lawsuits say Eli Lilly did not warn about serious risks like stomach paralysis, kidney injury, and vision loss. Over 3,300 cases, including Zepbound, are now in federal court. Many users say side effects do not go away even after stopping the drug.
His career began in public service as a Surveillance Officer in Maricopa County, where he gained firsthand experience in high-stakes decision-making and developed a deep sense of discipline and accountability. He later served as Chief Operating Officer of a fast-growing law firm, driving efficiency, revenue growth, and team development. Today, Ryan focuses on helping law firms reach their full potential by aligning people, processes, and long-term vision. A strategic thinker and empowering leader, Ryan is passionate about developing others and guiding organizations through meaningful, lasting growth.
Effective Date: 10/15/2026
Ethen Ostroff Law, PLLC (“EOL,” “we,” “us,” or “our”) respects your privacy. If you are reaching out to us after an injury, we know you may be sharing personal details during a hard time. This Privacy Policy explains what information we collect when you visit ethenostrofflaw.com (the “Site”), how we use it, who we share it with, and the choices you have.
This Privacy Policy works together with our Terms of Use. By using the Site, you agree to the practices described here. If you do not agree, please do not use the Site.
Visiting the Site, submitting a form, chatting with us online, or sending us an email does not create an attorney-client relationship. An attorney-client relationship begins only when you and EOL sign a written Retainer Agreement. Until then, information you send us is not protected by attorney-client privilege and is not considered confidential. Please do not send sensitive details about your matter until we have spoken with you.
When you request a free consultation, fill out a form, use our live chat, call, text, or email us, you may give us:
When you visit the Site, we and the third-party tools described in section 8 may automatically collect:
We may share your information with:
If you opt in to text messages, you may receive messages about your inquiry or case. Message frequency varies, and message and data rates may apply. Reply STOP at any time to opt out, or HELP for help. Mobile phone numbers and text message opt-in consent will not be shared with third parties or affiliates for their own marketing purposes.
We do not send the details you type into our intake forms, contact forms, or live chat, such as information about your injury or legal matter, to Google, Meta, TikTok, Reddit, or any other advertising platform.
The Site uses cookies, pixels, and similar tools. A cookie is a small file stored in your browser. A pixel is a small piece of code that loads when you visit a page and sends information about your visit to the company that provides it. We use Google Tag Manager to load and manage these tools.
The table below lists the third-party tools on the Site and what we use them for.
| Provider | What we use it for | Provider privacy policy |
| Google Tag Manager | Loads and manages the other tools listed here. It does not build a profile of you. | policies.google.com/privacy |
| Google Analytics | Understanding how visitors use the Site, such as pages viewed and how they found us. | policies.google.com/privacy |
| Google Ads | Measuring ad conversions and showing our ads to past visitors. | policies.google.com/privacy |
| Meta Pixel (Facebook and Instagram) | Measuring ad performance, showing our ads to past visitors, and reaching similar audiences. | facebook.com/privacy/policy |
| TikTok Pixel | Measuring ad performance, showing our ads to past visitors, and reaching similar audiences. | tiktok.com/legal/privacy-policy |
| Reddit Pixel | Measuring ad performance, showing our ads to past visitors, and reaching similar audiences. | reddit.com/policies/privacy-policy |
| Intaker | Powers the live chat on the Site so you can reach our intake team. | intaker.com |
| OpenWidget (ChatBot.com) | Powers the chat assistant on the Site. | openwidget.com |
| Google reCAPTCHA | Protects our forms from spam and automated abuse. | policies.google.com/privacy |
| Google Maps | Displays maps of our office locations. | policies.google.com/privacy |
These tools may collect the information listed in section 3. If you give us your email address or phone number, a scrambled (hashed) version may be sent to an advertising platform so it can match your visit to an existing account.
Google, Meta, TikTok, and Reddit may combine the information they receive with other data they hold about you and use it under their own privacy policies. You can learn how Google uses information from sites that use its services at policies.google.com/technologies/partner-sites.
Some state privacy laws, including California’s, may treat sharing information through advertising pixels as a “sale” or “sharing” of personal information, or as targeted advertising. Depending on where you live, you may have the right to know what information we hold about you, to ask us to correct or delete it, and to opt out of its sale or sharing. To make a request, contact us using the information in section 15. We may need to verify your identity before we respond. We will not treat you differently for using these rights.
We use reasonable administrative, technical, and physical safeguards to protect your information. No method of sending or storing data over the internet is completely secure, so we cannot guarantee the security of information you send us.
We keep your information as long as we need it for the purposes described in this policy, including to meet legal, ethical, and record-keeping obligations.
The Site is not directed to children under 13, and we do not knowingly collect personal information from them online. If a parent or guardian is contacting us about a child’s injury, the parent or guardian should submit the inquiry.
We may update this policy when we add, change, or remove tools on the Site or change how we handle information. We will post the updated version here and change the effective date above.
If you have questions about this policy or want to make a privacy request, contact us:
